# The Optimal Timing of the Initiation of Esophagogastroduodenoscopy After Oral Lidocaine Spray

> **NCT06497296** · NA · RECRUITING · sponsor: **National Cheng-Kung University Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Blood Pressure
- Tachycardia

## Interventions

- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT06497296
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06497296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06497296, "The Optimal Timing of the Initiation of Esophagogastroduodenoscopy After Oral Lidocaine Spray". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06497296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*